BCL-2 (BSB-5 (BCL2.A4)) Mouse
BCL-2 (BSB-5 (BCL2.A4)) Mouse
| Application | IHC |
| Clone | BSB-5 (BCL2.A4) |
| Conjugué | Unconjugated |
| Conseil | |
| Couleur | |
| Hôte | Mouse |
| Immunogène | Synthetic peptide corresponding to residues in the N-terminus of human bcl2 |
| Isotype | IgG1 kappa |
| Localisation | Cytoplasmic, Membranous |
| Pathologie | Lymphoma, Endometrial, Genital Cancer, Prostate Cancer, Breast Cancer, Lung Cancer |
| Predicted reactivity | |
| Purification | |
| Réactivité | Human |
| Spécificité | |
| Taille | |
| Tissus controles | Tonsil, Lymph Node, Breast, Bone Marrow, Fallopian Tube |
Prêt à l'emploi
| Conditionnement | Reference | Supplier | Certification | Dilution | TDS | Quantity |
|---|---|---|---|---|---|---|
| 7 ml | BSB5072 |
|
IVD/CE | RTU |
|
|
| 3 ml | BSB5071 |
|
IVD/CE | RTU |
|
|
| 15 ml | BSB5073 |
|
IVD/CE | RTU |
|
Concentré
| Conditionnement | Reference | Supplier | Certification | Dilution | TDS | Quantity |
|---|---|---|---|---|---|---|
| 1 ml | BSB5076 |
|
IVD/CE | 1/50 - 1/200 |
|
|
| 0,5 ml | BSB5075 |
|
IVD/CE | 1/50 - 1/200 |
|
|
| 0,1 ml | BSB5074 |
|
IVD/CE | 1/50 - 1/200 |
|
Control Slides
| Conditionnement | Reference | Supplier | Certification | Dilution | TDS | Quantity |
|---|---|---|---|---|---|---|
| 5 slides | BSB5077 |
|
IVD/CE |
|
||
| 5 slides | BSB9029-CS |
|
IVD/CE |
|